"metastatic colorectal cancer" trang 5 - tải miễn phí từ tailieuXANH
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: A retrospective analysis

Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: A retrospective analysis
11    82    0
Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: Case report and literature review

Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: Case report and literature review
3    53    0
Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma
12    65    0
Myxoid liposarcoma: Local relapse and metastatic pattern in 43 patients

Myxoid liposarcoma: Local relapse and metastatic pattern in 43 patients
7    58    0
A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: A retrospective study

A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: A retrospective study
9    61    0
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): An open-label, non-randomized, multicenter, phase IV clinical trial
7    74    0
SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients

SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
7    69    0
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
8    85    0
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
9    65    0
Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience

Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience
8    56    0
Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme
8    68    0
Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
6    64    0
The changing landscape of phase II/III metastatic sarcoma clinical trials - analysis of ClinicalTrials.gov

The changing landscape of phase II/III metastatic sarcoma clinical trials - analysis of ClinicalTrials.gov
9    68    0
Prognostic factors for survival with nabpaclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study

Prognostic factors for survival with nabpaclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
11    67    0
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: Results of matching-adjusted indirect comparison analyses

Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: Results of matching-adjusted indirect comparison analyses
12    75    0
A modified subclassification to evaluate the survival of patients with N3 gastric cancer: An international database study

A modified subclassification to evaluate the survival of patients with N3 gastric cancer: An international database study
10    74    0
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: Analysis from a randomised, double-blind phase II study
11    70    0
Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: Results from mCRC biomarker study

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: Results from mCRC biomarker study
7    70    0
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea
8    59    0
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
15    123    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.